Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study

INTRODUCTION: The objective of this study was to evaluate the efficacy and safety of decitabine in Chinese patients with myelodysplastic syndrome (MDS). METHODS: Patients (≥18 years) who had a de novo or secondary MDS diagnosis according to French–American–British classification and an International...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Depei, Du, Xin, Jin, Jie, Xiao, Zhijian, Shen, Zhixiang, Shao, Zonghong, Li, Xiao, Huang, Xiaojun, Liu, Ting, Yu, Li, Li, Jianyong, Chen, Baoan, He, Guangsheng, Cai, Zhen, Liang, Hongchuang, Li, Jigang, Ruan, Changgeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662721/
https://www.ncbi.nlm.nih.gov/pubmed/26568466
http://dx.doi.org/10.1007/s12325-015-0263-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662721/
https://www.ncbi.nlm.nih.gov/pubmed/26568466
http://dx.doi.org/10.1007/s12325-015-0263-8

Ejemplares similares